Correspondence:
We read with interest Van Tassel et al.’s “Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after female physicians” [1]. The study of medical eponyms unearths many interesting stories: some are interesting trivia (did Adolf von Baeyer really name barbiturates for a Bavarian barmaid called Barbara? [2]), others are profoundly upsetting (Hans Eppinger’s investigation of concentration camp prisoners’ life expectancy with only salt water to drink [3]). The description of gender imbalance among medical eponyms is certainly a worthy addition to the field.
In their opening paragraph Van Tassel et al. repeat the common assertion that there has been a “decline in eponym use”. In 2016, we described the rise and fall of 8636 extant and extinct medical eponyms in PubMed’s database of around 25 million articles spanning two centuries [4]. In Fig. 1 we present a new subset analysis of the use of 291 ophthalmic eponyms. The findings are consistent with those of the broader dataset. Eponyms are today used in the titles of more PubMed indexed entries than at any time in the past, and the annual growth remains rapid. Accounting for the inexorably increasing number of publications per year, we find a modest decrease in the prevalence of eponyms since their peak in the 1990s (to the levels seen around 1980). We find evidence to suggest that this decreasing prevalence can in part be accounted for by an increasing non-clinical presence on PubMed (by comparing eponym use to clinical words like “artery”). There was also evidence in our original study [4] (by comparison to a historical index of eponyms), that studies like ours are likely to underestimate eponym coinage—newly coined eponyms are not yet present in lists of common medical eponyms. Interestingly, we also found that coinage of well-established eponyms was brisk at the time that articles mourning their loss were originally being written [5].
In summary, there is no convincing evidence that medical or ophthalmic eponyms are in precipitous decline. Perpetuating the idea that they are could become self-fulfilling, discouraging new eponym coinage. This will do nothing to create a more even gender balance among medical eponyms.
References
Van Tassel SH, Segal KL, Ciralsky JB, Sun G. Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after female physicians. Eye. 2018;32:1293–5.
Youngson RM. Medical curiosities. London: Robinson Publishing; 1997.
Strous RD, Edelman MC. Eponyms and the Nazi era: time to remember and time for change. Isr Med Assoc J. 2007;9:207–14.
Thomas P. Are medical eponyms really dying out? A study of their usage in the historical biomedical literature. J R Coll Physicians Edinb. 2016;46:295–9.
Gordon-Talylor G. In defence of eponyms. J R Coll Surg Edinb. 1959;4:105–20.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Thomas, P.B.M., Gunasekera, C.D. Comment on: Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after female physicians. Eye 33, 850–859 (2019). https://doi.org/10.1038/s41433-018-0313-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-018-0313-y